IDEXX Laboratories, Inc. (IDXX) Q3 2015 Earnings Results

IDEXX Laboratories Beats on EPS, Stock Down 10.19%

IDEXX Laboratories reported a slight earnings beat with an EPS of $0.54, but the stock fell by over 10% in reaction. The decline may reflect investor concerns or broader market conditions, as no revenue figures or management commentary were provided to clarify the results.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.54	N/A	+2.08%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Unknown

No transcript is on record, and the analysis is based on numerical results only.

IDEXX Laboratories Beats on EPS, Stock Down 10.19%

Key numbers

Management commentary

IDEXX Laboratories, Inc.

More earnings this week

IDEXX Laboratories Beats on EPS, Stock Down 10.19%

Key numbers

Management commentary